Chiesi Ventures

Profile and portfolio

Parent Chiesi GroupHQ Parma, ItalyFounded 2014

Chiesi Ventures is the corporate venture arm of Chiesi Group, a pharmaceutical and biotech company. It was founded in 2014 and is based in Parma, Italy. It invests at the seed stage. Sectors it names: biotech and life sciences.

Companies backedS3: 9
IPOsS3: 4

Every figure links to its source

Snapshot

Investment stage: Seed to Seed

Data behind this graphic

Data behind this graphic
Item	Value
Stage range	Seed to Seed
Sectors	Biotech and life sciences
Geography	North America, Europe
Offices	Parma, Italy, Boston, United States, Research Triangle Park, United States

Sources: S1 Chiesi Ventures home page.

Scale and capital allocated

Data behind this graphic

Data behind this graphic
Measure	Value	Unit	Kind	Source
Companies backed	9	companies	Stated by the firm	S3
IPOs	4	IPOs	Stated by the firm	S3
Companies on the firm's portfolio page	9	companies	Counted from the firm's own list	S3

Sources: S3 Chiesi Ventures: Portfolio Companies.

Where it invests and who leads it

Geography

Headquarters: Parma, Italy
Offices: Parma, Italy
Boston, United States
Research Triangle Park, United States

Investment regionsS1

LeadersS2

Giacomo ChiesiManaging PartnerFind on LinkedIn Firm page
Arthur M. PappasInvestment Committee member; CEO, Pappas CapitalFind on LinkedIn Firm page

Chiesi Ventures on LinkedIn

Key facts

Fact	Value	Status	Source
Parent company	Chiesi Group	Single source	S1
Parent industry	Pharmaceuticals and biotech	Single source	S1
Founded	2014	Single source	S2
Headquarters	Parma, Italy	Single source	S1
Status	Active	Single source	S1
Companies backed	9	Single source	S3
Exits	5 total, 4 IPOs	Single source	S3
Stages	Seed (inferred from announced rounds)	Estimate	S1

Notable outcomes

IPOs and acquisitions of portfolio companies. Price shown only where published.

Company	Type	Acquirer or exchange	Source
Mirum Pharmaceuticals	IPO	NASDAQ	S3
4D Molecular Therapeutics	IPO	NASDAQ	S3
Aura Biosciences	IPO	NASDAQ	S3
Kezar Life Sciences	IPO	NASDAQ	S3
VelosBio	Acquisition	Merck	S3

Portfolio

The firm's portfolio page lists 9 companies.S3

Shared portfolio with other corporate VCs

2 companies on the Chiesi Ventures portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

Firm	Shared	Companies in common
Asahi Kasei Therapeutics Venture Capital	1	Glycomine
Asahi Kasei Ventures	1	Glycomine
Sanofi Ventures	1	Glycomine
Pfizer Ventures	1	4D Molecular Therapeutics

Companies backed by the most corporate VCs

Every company on the Chiesi Ventures list

9 companies, as listed on the firm's own website.S3 Read the firm's list.

4D Molecular Therapeutics
Aura Biosciences
CuraSen Therapeutics
Glycomine
Kezar Life Sciences
Minoryx Therapeutics
Mirum Pharmaceuticals
Sentien Biotech
VelosBio

History

2014Chiesi Ventures founded; strategic collaboration with Pappas Capital announced 2 Sep 2014S2

Official pages

Read the firm's own pages for current information.

Website www.chiesiventures.com
Portfolio www.chiesiventures.com/portfolio-companies/

Sources

S1Chiesi Ventures home pageFirm
S2Chiesi Ventures: Team and GovernanceFirm
S3Chiesi Ventures: Portfolio CompaniesFirm
S4Pappas Capital: Chiesi Ventures FundThird-party report

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Chiesi Ventures or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.

Report a correction